Biostem main logo .png
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
August 29, 2024 07:00 ET | BioStem Technologies, Inc.
BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
Biostem main logo .png
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
August 21, 2024 07:00 ET | Biostem Technologies
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje®
Biostem main logo .png
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
August 12, 2024 16:14 ET | Biostem Technologies
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
Biostem main logo .png
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
August 05, 2024 08:00 ET | Biostem Technologies
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
Biostem main logo .png
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
July 10, 2024 07:15 ET | Biostem Technologies
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
Biostem main logo .png
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
June 26, 2024 08:30 ET | Biostem Technologies
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
Biostem main logo .png
BioStem Technologies to Sponsor MRO Better Half Dash
May 29, 2024 11:00 ET | Biostem Technologies
BioStem Technologies to Sponsor MRO Better Half Dash
Biostem main logo .png
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
May 14, 2024 16:01 ET | Biostem Technologies
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
Biostem main logo .png
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
May 07, 2024 08:00 ET | Biostem Technologies
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
Biostem main logo .png
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
May 06, 2024 08:00 ET | Biostem Technologies
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent